Xarelto is a newer blood thinner that has been on the market since 2011.
Its primary function is to reduce the risk of blood clots in patients
who have Deep Vein Thrombosis, pulmonary embolism, or have undergone a
knee or hip replacement. Unlike older blood thinners, such as Heparin
or Coumadin, patients taking Xarelto do not need to undergo regular blood
testing and there are fewer known drug and food interactions. Yet, unlike
traditional blood thinners – there is no known antidote to Xarelto.
So, when a patient begins to bleed uncontrollably, there is little a physician
can do to effectively stop these bleeds. Heparin and Coumadin both have
a well-known anecdote to stop such bleeding.
Since the FDA first approved Xarelto, it has been prescribed more than
11 million times in America alone. During that time there have been more
than 1,800 adverse events reported, including pulmonary embolisms, deep
vein thrombosis, and gastrointestinal bleeds. During the first eight months
of 2013 alone, there were 968 reports of serious Xarelto side effects
and 72 Xarelto deaths. In 2012, there were more than 750 reports of serious
Xarelto side effects and 58 Xarelto deaths. Pulmonary embolism is the
most common injury sustained from taking Xarelto, but deep vein thrombosis
and gastrointestinal hemorrhage are risks as well.
Now, a study published in the British Medical Journal concludes that Xarelto
use could actually double the risk for gastrointestinal bleeding (GI Bleeds).
The study reviewed 45,000 patients who took Xarelto and determined that
when compared to patients taking Warfarin, GI Bleeds occurred 2x more.
Xarelto Lawsuits Continue to Climb
Recently more than 400 Xarelto lawsuits were combined into an MDL overseen
by Judge Eldon Fallon of the Eastern District of Louisiana. These lawsuits
were filed by plaintiffs across the country who claim that Xarelto manufacturers,
Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals, failed
to provide adequate warnings regarding potential safety risks; failed
to study Xarelto's safety; failed to include black box warning regarding
risk of uncontrolled bleeding; and willfully withheld this information
Reasons to File a Xarelto Lawsuit
There are numerous reasons why injured patients and their families have
chosen to file a Xarelto lawsuit. The main reason is to hold negligent
pharmaceutical companies, Bayer and Janssen Pharmaceuticals, accountable
for their actions and to prevent future injuries and deaths from this
dangerous drug. Many patients also file a lawsuit because they have incurred
serious injuries, leading to massive medical bills and financial hardship.
There may have been emergency room visits, hospitalization, surgeries,
and ongoing care. For families of loved ones who have died because of
Xarelto, there is also the burden of funeral expenses, as well as the
loss of future income and the pain and suffering that accompanies losing
a loved one.
Contact Our National Dangerous Drug Lawyers
If you have suffered medical complications, pain, or excessive bleeding
after using Xarelto, your injuries may be the result of a drug manufacturer's
negligence. To learn more about your legal options or to schedule a free
consultation call the Philadelphia class action lawyers at Golomb &
Honik, P.C. today at (800) 355-3300 or (215) 985-9177 or fill out our
confidential Contact Form.
The national dangerous drug lawyers at Golomb & Honik, P.C. have successfully
represented individuals in Philadelphia, Pennsylvania, New Jersey, and
throughout the United States.